Athyrium Opportunities III Acquisition 2 LP 13D and 13G filings for Amryt Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-18 4:15 pm Sale | 2023-04-12 | 13G | Amryt Pharma plc AMYT | Athyrium Opportunities III Acquisition 2 LP | 0 0.000% | -44,286,346 (Position Closed) | Filing |
| 2021-02-12 08:01 am Purchase | 2020-07-08 | 13G | Amryt Pharma plc AMYT | Athyrium Opportunities III Acquisition 2 LP | 44,286,346 24.800% | 44,286,346 (New Position) | Filing |